KEQU on Nasdaq

KEWAUNEE SCIENTIFIC CORP /DE/

American laboratory apparatus and furniture company based in Dover. Summary from the record

Price unavailable

Last updated Oct 19, 2026.

Overview

$282.0MRevenue, fiscal 20263
$9.6MNet income, fiscal 20263

Compare with REFLECT SCIENTIFIC, INC., or pick any stock.

  • TickerKEQU on Nasdaq2
  • IndustryLaboratory Apparatus & Furniture2
  • HeadquartersDover, United States2
  • Incorporated inDE4
  • Business address2700 W Front St, Statesville, Nc 286774
  • Filer categoryNon-accelerated filer, Smaller reporting company4
  • Legal formCorporation2
  • LEI549300Z8MHH8NUYXQ2292
  • StatusActive2
  • LEI statusLapsed (not renewed)2
  • Registered addressC/O NATIONAL REGISTERED AGENTS, INC., 19904 Dover, United States2
  • Registered withDivision of Corporations, Department of State, 7545172

See how the biggest companies compare on our leaderboards

Kewaunee Scientific Corporation (the "Company") was founded in 1906, incorporated in Michigan in 1941, became publicly-held in 1968, and was reincorporated in Delaware in 1970. Our principal business is the design, manufacture, and installation of laboratory, healthcare, and technical furniture and infrastructure products. Our products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. Our acquisition of Nu Aire, Inc., ("Nu Aire"), completed in November 2024, complements the Company's portfolio through Nu Aire's biological safety cabinets, CO2 incubators, ultralow freezers, and other essential laboratory products. Nu Aire is renowned for its manufacturing of biological safety cabinets, airflow products, CO2 incubators, ultralow freezers, animal handling eq…5 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2026

28.5%Gross margin3
5.9%Operating margin3
3.4%Net margin3
17.3%Revenue growth, 20263
12.9%Return on equity3
0.20×Debt to equity3

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Business segments

"Laboratory Products Group (""LPG"") [Member]" brought in 76% of the revenue KEWAUNEE SCIENTIFIC CORP /DE/ broke down this way in fiscal 2026.

  1. "Laboratory Products Group (""LPG"") [Member]"$214.9M376%up 20% from 2025
  2. International Operations$67.1M324%up 10% from 2025
Business segments by year
Business segments20252026
"Laboratory Products Group (""LPG"") [Member]"$179.4M$214.9M
International Operations$61.1M$67.1M

Where the money goes

Where each dollar of revenue went, fiscal 2026

  • Cost of revenue71¢$201.6M
  • Research and development0¢$898.0K
  • Other costs24¢$66.7M
  • Income tax1¢$3.3M
  • Profit3¢$9.6M

Out of $282.0M in revenue.3

Where each dollar of operating cash went, fiscal 2026

  • Kept or used elsewhere100¢$18.6M

Out of $18.6M of cash from operations.3

Financial statements

Revenue678910113$282.0M in 2026+92% since 2019
0$100.0M$200.0M$300.0M2019: $146.6M$146.6M20192020: $147.5M$147.5M2020+1%2021: $147.5M$147.5M2021−0%2022: $168.9M$168.9M2022+15%2023: $219.5M$219.5M2023+30%2024: $203.8M$203.8M2024−7%2025: $240.5M$240.5M2025+18%2026: $282.0M$282.0M2026+17%
Gross profit678910113$80.4M in 2026+218% since 2019
0$25.0M$50.0M$75.0M$100.0M2019: $25.3M$25.3M20192020: $23.4M$23.4M2020−7%2021: $24.0M$24.0M2021+2%2022: $24.2M$24.2M2022+1%2023: $35.6M$35.6M2023+47%2024: $52.1M$52.1M2024+46%2025: $68.9M$68.9M2025+32%2026: $80.4M$80.4M2026+17%
Operating income678910113$16.7M in 2026+691% since 2019
-$10.0M0$10.0M$20.0M2019: $2.1M$2.1M20192020: -$2.3M-$2.3M20202021: -$1.3M-$1.3M2021−44%2022: -$2.6M-$2.6M2022+98%2023: $5.4M$5.4M20232024: $18.3M$18.3M2024+241%2025: $17.8M$17.8M2025−3%2026: $16.7M$16.7M2026−6%
Net income678910113$9.6M in 2026+529% since 2019
-$10.0M0$10.0M$20.0M2019: $1.5M$1.5M20192020: -$4.7M-$4.7M20202021: -$3.7M-$3.7M2021−22%2022: -$6.1M-$6.1M2022+67%2023: $738.0K$738.0K20232024: $18.8M$18.8M2024+2441%2025: $11.4M$11.4M2025−39%2026: $9.6M$9.6M2026−16%

Every line of the income statement as filed: the last 2 fiscal years, latest first.3

Period ending2026-04-302025-04-30
Net sales$282.0M$240.5M
Cost of products sold$201.6M$171.6M
Gross profit$80.4M$68.9M
Operating expenses$63.7M$51.1M
Operating earnings$16.7M$17.8M
Other income, net$880.0K$240.0K
Interest expense-$3.9M-$3.2M
Total earnings before income tax expense$13.7M$14.8M
Income tax expense$3.3M$3.2M
Net earnings$10.5M$11.6M
Less: net earnings attributable to the non-controlling interest$847.0K$178.0K
Net earnings attributable to Kewaunee Scientific Corporation$9.6M$11.4M
Basic (in usd per share)$3.36$3.98
Diluted (in usd per share)$3.22$3.83
Basic (in shares)2.9M shares2.9M shares
Diluted (in shares)3.0M shares3.0M shares

Compare KEWAUNEE SCIENTIFIC CORP /DE/ with another company

Leadership

Who has led KEWAUNEE SCIENTIFIC CORP /DE/, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. William A. Shumaker2007–2013
  2. David M. Rausch2013–2018
  3. Thomas David Hull Iii.2019–now

President

  1. William A. Shumaker2007–2011
  2. David M. Rausch2012–2018
  3. Thomas David Hull Iii.2019–now

Chief financial officer

  1. David Michael Parker2008–2015
  2. Thomas David Hull Iii.2015–2018
  3. Donald T. Gardner Iii.2019–now

Chief operating officer

  1. David M. Rausch2012–2013
2010201520202025
Board members and other officers (26)

Timeline

  1. Jun 21, 2019New chief executive Thomas David Hull Iii. becomes CEO16
  2. Jul 10, 2013New chief executive David M. Rausch becomes CEO17
  3. Mar 12, 2007New chief executive William A. Shumaker becomes CEO18

Filings

282 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 58 major events, 141 insider forms, 13 large holders, 50 other. The latest 20:

  1. Sep 11, 202610-Q EDGAR
  2. Sep 9, 20268-K EDGAR
  3. Aug 27, 20268-K EDGAR
  4. Aug 26, 20268-K EDGAR
  5. Aug 25, 20268-K EDGAR
  6. Jul 7, 2026ARS EDGAR
  7. Jul 7, 2026DEFA14A EDGAR
  8. Jul 7, 2026DEF 14A EDGAR
  9. Jul 2, 20264 EDGAR
  10. Jul 2, 20264 EDGAR
  11. Jul 2, 20264 EDGAR
  12. Jul 2, 20264 EDGAR
  13. Jul 2, 20264 EDGAR
  14. Jul 2, 20264 EDGAR
  15. Jun 29, 2026SCHEDULE 13G/A EDGAR
  16. Jun 26, 202610-K EDGAR
  17. Jun 25, 20264 EDGAR
  18. Jun 25, 20264 EDGAR
  19. Jun 25, 20264 EDGAR
  20. Jun 25, 20264 EDGAR

The 282 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

58 open-market trades by officers, directors and large owners since October 2021: 9 buys and 49 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Jan 7, 2026HULL THOMAS DAVID IIIPresident & CEOSale2,177$37.50$81.6KForm 4
Jan 6, 2026Gardner Donald T. IIIChief Financial OfficerSale2,000$37.57$75.1KForm 4
Dec 31, 2025HULL THOMAS DAVID IIIPresident & CEOSale629$37.66$23.7KForm 4
Dec 30, 2025HULL THOMAS DAVID IIIPresident & CEOSale29$38.00$1.1KForm 4
Dec 29, 2025HULL THOMAS DAVID IIIPresident & CEOSale884$38.01$33.6KForm 4
Dec 22, 2025HULL THOMAS DAVID IIIPresident & CEOSale1,000$39.00$39.0KForm 4
Dec 17, 2025HULL THOMAS DAVID IIIPresident & CEOSale1,000$39.00$39.0KForm 4
Oct 9, 2025Gardner Donald T. IIIChief Financial OfficerSale3,000$42.76$128.3KForm 4
Oct 2, 2025Phillips Elizabeth DSVP, People & CultureSale6,880$43.20$297.2KForm 4
Oct 1, 2025HULL THOMAS DAVID IIIPresident & CEOSale1,000$43.09$43.1KForm 4
Sep 29, 2025HULL THOMAS DAVID IIIPresident & CEOSale1,854$43.42$80.5KForm 4
Sep 24, 2025HULL THOMAS DAVID IIIPresident & CEOSale1,000$43.62$43.6KForm 4
Sep 23, 2025HULL THOMAS DAVID IIIPresident & CEOSale721$44.00$31.7KForm 4
Sep 19, 2025HULL THOMAS DAVID IIIPresident & CEOSale773$45.34$35.0KForm 4
Sep 18, 2025HULL THOMAS DAVID IIIPresident & CEOSale652$46.00$30.0KForm 4
Jul 24, 2025Gardner Donald T. IIIChief Financial OfficerSale3,000$58.59$175.8KForm 4
Apr 14, 2025HULL THOMAS DAVID IIIPresident & CEOSale1,844$32.44$59.8KForm 4
Apr 10, 2025Gardner Donald T. IIIChief Financial OfficerSale1,000$35.18$35.2KForm 4
Apr 9, 2025Gardner Donald T. IIIChief Financial OfficerSale3,000$37.75$113.2KForm 4
Apr 4, 2025GEHL KEITH MDirectorBuy1,000$35.00$35.0KForm 4

All 58 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 32. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Northern Trust Corp238,111$8.5M0.0%−7,853
Dimensional Fund Advisors LP175,042$6.2M0.0%−2,297
Minerva Advisors LLC149,410$5.3M3.4%+12,705
Vanguard Capital Management LLC110,051$3.9M0.0%−2,462
Punch & Associates Investment Management, Inc.105,545$3.7M0.2%+4,843
Renaissance Technologies LLC95,311$3.4M0.0%−3,200
De Lisle Partners LLP52,626$1.9M0.2%No change
Royce & Associates LP49,700$1.8M0.0%+1,700
American Century Companies Inc49,530$1.8M0.0%−21
Geode Capital Management, LLC24,931$885.8K0.0%+452
Mink Brook Asset Management LLC21,447$761.8K0.3%No change
Northeast Investment Management20,000$710.4K0.0%No change
Morgan Stanley16,828$597.7K0.0%−3,106
Vanguard Fiduciary Trust Co13,172$467.9K0.0%+88
Wealth Enhancement Advisory Services, LLC12,694$464.5K0.0%No change
BlackRock, Inc.11,978$425.5K0.0%+2,054
Bridgeway Capital Management, LLC11,815$419.7K0.0%No change
State Street Corp10,034$356.4K0.0%No change
Verdad Advisers, LP10,000$355.2K0.3%New
LPL Financial LLC8,000$284.2K0.0%No change
Arrowstreet Capital, Limited Partnership6,617$235.0K0.0%No change
IFP Advisors, Inc810$28.8K0.0%+225
Vanguard Global Advisers, LLC800$28.4K0.0%No change
Royal Bank Of Canada800$28.0K0.0%+400
Barclays PLC680$24.2K0.0%−1,457

13F reports cover disclosed long positions in U.S. stocks only.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50